Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 18, Pages 6914
Publisher
MDPI AG
Online
2020-09-21
DOI
10.3390/ijms21186914
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease
- (2020) Hamel Patel et al. JOURNAL OF ALZHEIMERS DISEASE
- Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study
- (2020) Ming-Jang Chiu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
- (2020) Dieter Volc et al. LANCET NEUROLOGY
- Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
- (2019) D. J. Marciani Research
- The advent of AI and deep learning in diagnostics and imaging
- (2019) Philip Hunter EMBO REPORTS
- Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
- (2019) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
- (2019) Lin et al. Journal of Clinical Medicine
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
- (2018) Charlotte E. Teunissen et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
- (2018) Chin-Hsien Lin et al. Frontiers in Aging Neuroscience
- The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
- (2018) Ling-Yun Fan et al. Frontiers in Aging Neuroscience
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- DMAP: a connectivity map database to enable identification of novel drug repositioning candidates
- (2015) Hui Huang et al. BMC BIOINFORMATICS
- Age-related neurodegenerative disease research needs aging models
- (2015) Ian P. Johnson Frontiers in Aging Neuroscience
- mice: Multivariate Imputation by Chained Equations inR
- (2015) Stef van Buuren et al. Journal of Statistical Software
- Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
- (2014) David J. Irwin et al. ACTA NEUROPATHOLOGICA
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
- (2013) Yaroslau Compta et al. Neurodegenerative Diseases
- Blood-based biomarkers for Parkinson's disease
- (2013) Lama M. Chahine et al. PARKINSONISM & RELATED DISORDERS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer’s Disease in Vitro
- (2011) Che-Chuan Yang et al. ACS Chemical Neuroscience
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Pathological correlates of frontotemporal lobar degeneration in the elderly
- (2010) Atik Baborie et al. ACTA NEUROPATHOLOGICA
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- Biomarker discovery in neurodegenerative diseases: A proteomic approach
- (2008) Min Shi et al. NEUROBIOLOGY OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started